223 related articles for article (PubMed ID: 32721962)
1. Gut Microbiome and AKI: Roles of the Immune System and Short-Chain Fatty Acids.
Gharaie S; Noel S; Rabb H
Nephron; 2020; 144(12):662-664. PubMed ID: 32721962
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
[TBL] [Abstract][Full Text] [Related]
3. The Microbiome and Acute Kidney Injury.
Rabb H; Pluznick J; Noel S
Nephron; 2018; 140(2):120-123. PubMed ID: 29961049
[TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota control acute kidney injury severity by immune modulation.
Yang J; Kim CJ; Go YS; Lee HY; Kim MG; Oh SW; Cho WY; Im SH; Jo SK
Kidney Int; 2020 Oct; 98(4):932-946. PubMed ID: 32470493
[TBL] [Abstract][Full Text] [Related]
5. Significance of the Gut Microbiota in Acute Kidney Injury.
Kobayashi T; Iwata Y; Nakade Y; Wada T
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34067285
[TBL] [Abstract][Full Text] [Related]
6. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
Huang W; Zhou L; Guo H; Xu Y; Xu Y
Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived D-serine protects against acute kidney injury.
Nakade Y; Iwata Y; Furuichi K; Mita M; Hamase K; Konno R; Miyake T; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Sato K; Oshima M; Yoneda-Nakagawa S; Yamamura Y; Kaneko S; Miyamoto T; Katane M; Homma H; Morita H; Suda W; Hattori M; Wada T
JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333299
[TBL] [Abstract][Full Text] [Related]
8. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
Chou YT; Kan WC; Shiao CC
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
[TBL] [Abstract][Full Text] [Related]
9. Research progress in the role of gut microbiota in acute kidney injury.
Chen T; Chang C; Hou B; Qiu L; Sun H; Zhu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):385-391. PubMed ID: 38970512
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury.
Zou YT; Zhou J; Zhu JH; Wu CY; Shen H; Zhang W; Zhou SS; Xu JD; Mao Q; Zhang YQ; Long F; Li SL
Microbiol Spectr; 2022 Jun; 10(3):e0075922. PubMed ID: 35481834
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.
Pluznick JL
Kidney Int; 2016 Dec; 90(6):1191-1198. PubMed ID: 27575555
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
13. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Microbiota in Experimental Acute Kidney Injury.
Shah N; Rabb H
Nephron; 2023; 147(1):25-30. PubMed ID: 36195072
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress of Short Chain Fatty Acids in the Pathogenesis of Immune Thrombocytopenia--Review].
Li XN; Qu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1296-1300. PubMed ID: 35981402
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases.
Ikeda T; Nishida A; Yamano M; Kimura I
Pharmacol Ther; 2022 Nov; 239():108273. PubMed ID: 36057320
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
19. The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling-A Systematic Review.
Rydzewska-Rosołowska A; Sroka N; Kakareko K; Rosołowski M; Zbroch E; Hryszko T
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33322362
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.
Aragonès G; González-García S; Aguilar C; Richart C; Auguet T
Biomed Res Int; 2019; 2019():8507583. PubMed ID: 30719448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
